The small subunit of calpain, a calciumdependent cysteine protease, was found to interact with the cytoplasmic domain of the common cytokine receptor ␥ chain (␥ c ) in a yeast two-hybrid interaction trap assay. This interaction was functional as demonstrated by the ability of calpain to cleave in vitro-translated wild-type ␥ c , but not ␥ c containing a mutation in the PEST (proline, glutamate, serine, and threonine) sequence in its cytoplasmic domain, as well as by the ability of endogenous calpain to mediate cleavage of ␥ c in a calcium-dependent fashion. In T cell receptor-stimulated murine thymocytes, calpain inhibitors decreased cleavage of ␥ c . Moreover, in single positive CD4 ؉ thymocytes, not only did a calpain inhibitor augment CD3-induced proliferation, but antibodies to ␥ c blocked this effect. Finally, treatment of cells with ionomycin could inhibit interleukin 2-induced STAT protein activation, but this inhibition could be reversed by calpain inhibitors. Together, these data suggest that calpain-mediated cleavage of ␥ c represents a mechanism by which ␥ c -dependent signaling can be controlled.
؉ thymocytes, not only did a calpain inhibitor augment CD3-induced proliferation, but antibodies to ␥ c blocked this effect. Finally, treatment of cells with ionomycin could inhibit interleukin 2-induced STAT protein activation, but this inhibition could be reversed by calpain inhibitors. Together, these data suggest that calpain-mediated cleavage of ␥ c represents a mechanism by which ␥ c -dependent signaling can be controlled.
Mutation of the common cytokine receptor ␥ chain, ␥ c , results in X-linked severe combined immunodeficiency in humans (1, 2) . The severity of this disease is explained by the participation of ␥ c as an essential component of the receptors for interleukin (IL) 2, IL-4, IL-7, IL-9, and IL-15 (3) (4) (5) (6) (7) (8) (9) . The phenotype in humans with X-linked severe combined immunodeficiency (2) and in ␥ cdeficient mice (10) (11) (12) indicates the vital role played by ␥ c in intrathymic T cell development. In normal mice, ␥ c mRNA can be detected as early as day 13.5 in fetal thymus (C. Sommers and P. E. Love, personal communication) and in all subpopulations of mature thymocytes (13) , consistent with vital role(s) for ␥ c throughout thymic development. In addition to its roles in cytokine signaling and thymic development, signaling through ␥ c has been proposed to prevent T cell anergy, based on observations that after T cell receptor (TCR)-mediated signaling, IL-2, IL-4, and IL-7 each can prevent the induction of anergy (14) .
For the IL-2 receptor, heterodimerization of the cytoplasmic regions of ␥ c and IL-2R␤ is necessary and sufficient for signaling (15, 16) . IL-2R␤ has been reported to interact with multiple signaling molecules, including Lck (17) , Shc (18, 19) , Syk (20) , PI 3-kinase (21), Jak1 (8, 14, 22) , and STAT proteins (19, 23) . In contrast, the only signaling molecule known to interact with ␥ c is the Janus family tyrosine kinase, Jak3 (8, 14, 22) . We now report that the small subunit of the calcium-activated neutral protease, calpain, an enzyme implicated in T cell apoptosis (24) (25) (26) , can associate with ␥ c . We show that calpain can cleave ␥ c , that anti-CD3 treatment of freshly isolated thymocytes resulted in proteolysis of ␥ c , and that calpain-specific inhibitors protected against this proteolysis and could augment anti-CD3-induced proliferation. Moreover, ionomycin could inhibit IL-2-induced STAT protein activation, and calpain inhibitors reversed this effect. Proteolysis of ␥ c by calpain therefore may represent a mechanism of controlling levels of ␥ c , thereby modulating cytokine-dependent signaling responses.
MATERIALS AND METHODS
Yeast Two-Hybrid System. To generate the "bait plasmid" (pAS-CYH2-␥ c ), the human ␥ c cytoplasmic domain was amplified by PCR using sense (5Ј-ATCATCATCCATGGTGTATT-TCTGGCTGGAACG-3Ј; ϩ835 to ϩ854) and antisense (5Ј-ATCATCATGGATCCATCGGTTCAGGAACAATCGG-3Ј; ϩ1,409 to ϩ1,389) primers containing NcoI and BamHI sites, respectively (underlined), and subcloned between the NcoI and BamHI sites of pAS1-CYH2, allowing production in yeast of a Gal4 binding domain͞␥ c cytoplasmic domain fusion protein.
Y190 cells (MATa gal4 gal80 his3 trp1-901 ade2-101 ura3-52 leu2-3,-112 ϩ URA3::GAL-ϾlacZ, LYS2::GAL(UAS)-ϾHIS3 cyh r ) were transformed to Trp prototrophy with pAS1-CYH2-␥ c . Y190 cells contain two reporter genes, lacZ and HIS3, under Gal4 control, allowing the identification of cDNA clones encoding interacting proteins by ␤-galactosidase (␤-gal) production and by the growth of transformed cells on His Ϫ medium in the presence of 3-amino-1,2,4-triazole (27) . After confirming that pAS1-CYH2-␥ c by itself did not direct transcription of ␤-gal, Y190 (pAS1-CYH2-␥ c ) cells were transformed by the lithium acetate method using denatured sheared herring testes DNA as a carrier and approximately 10 7 clones from a cDNA library in which human Epstein-Barr virus-transformed B cell cDNAs were fused to the Gal4 activation domain in pACT (27) . Cells were plated on Leu Ϫ , Trp Ϫ , and His Ϫ plates with 25 mM 3-amino-1,2,4-triazole (Sigma) and incubated for up to 8 days at 30°C. His ϩ colonies were evaluated for ␤-gal activity using a filter-lift assay. After the bait construct was eliminated by plating on Leu Ϫ plates containing cycloheximide (27) , 347 ␤-gal ϩ clones were mated with Y187 yeast (MAT␣ gal4 gal80 his3 trp1-901 ade2-101 ura3-52 leu2-3,-112 met Ϫ URA3::GAL-ϾlacZ) carrying pAS1-CYH2 without an insert or with SNF-1 or p53 as fusion proteins with the Gal4 activation domain (negative control) or with the bait construct (positive control). The ␤-gal assay was used to eliminate nonspecific interactions, and 21 cDNA plasmids were rescued from yeast and transformed into bacteria. Plasmid DNAs were isolated and sequenced using either the PRISM ready reaction dyedeoxy terminator cycle sequencing kit (Applied Biosystems) or Sequenase.
In Vitro Translation of ␥ c and Cleavage with Calpain. In vitro translation reactions were performed using the TNT coupled wheat germ extract system (Promega), [ 35 
S]methionine (Am-
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, another potent inhibitor of calpain, were incubated in the presence of 5 mM CaCl 2 . The reaction was terminated with EGTA (10 mM final concentration) and the protease inhibitor mix. Immunoprecipitations were performed with immobilized anti-chicken IgY (Promega) and either chicken anti-human ␥ c antibody (Promega) or chicken IgY (HϩY) as a control antibody (Promega). After 3 hr at 4°C, immunoprecipitates were extensively washed in the same lysis buffer and analyzed on 10-20% Tricine SDS gels (NOVEX). Immunoblotting was carried out with R878 antiserum to the cytoplasmic tail of ␥ c (5, 6) and developed using ECL (Amersham).
For experiment in intact YT cells, cells were washed twice with calcium-free PBS and incubated for 30, 60, or 90 min with 5 M ionomycin (Sigma) and either 2.5 mM CaCl 2 or 0.5 mM EGTA in calcium-free PBS. Cells were lysed with Brij96 lysis buffer containing 5 mM EGTA and 2.5 mM EDTA and a protease inhibitor mix containing 10 g͞ml leupeptin (Boehringer Mannheim), 240 g͞ml 4-[2-aminoethyl]-benzenesulfonyl fluoride hydrochloride (ICN), and 10 g͞ml aprotinin (ICN). Lysates were immunoprecipitated with anti-␥ c antibody (Promega) and run on SDS gels (NOVEX). Gels were immunoblotted with R878 antiserum to ␥ c and developed using ECL. Cell lysates also were analyzed on 7.5% tris-glycine SDS gels and stained with Coomassie blue to evaluate nonspecific degradation during the incubation. To evaluate the doseresponsiveness of ionomycin on ␥ c cleavage, YT cells were treated with 0, 2, 20, or 40 M ionomycin, and ␥ c cleavage was evaluated as above. To confirm that IL-2 does not induce cleavage of ␥ c , YT cells were treated with 2 nM IL-2 in PBS containing 2.5 mM CaCl 2 for 60 min at 37°C, and ␥ c cleavage was evaluated by Western blotting with R878 antiserum.
TCR-Mediated ␥ c Proteolysis in Thymocytes. Murine thymocytes from 4-week-old C57BL͞6 mice were washed twice with calcium-free PBS and resuspended at 10 7 cells͞ml in RPMI medium 1640 containing 10% fetal bovine serum (FBS). Cells were preincubated for 15 min with 0 or 25 M AllnM (calpain inhibitor II; Calbiochem), a potent inhibitor of calpain (25) . Cells then were incubated with 20 g͞ml of purified hamster anti-mouse CD3 mAb (145-2C11, PharMingen) in RPMI medium 1640͞10% FBS for 15 min, and then crosslinked using 60 g͞ml of affinity-purified, unconjugated goat anti-hamster IgG (GAHIgG, Jackson Immunoresearch) (29) for the indicated periods of time. Cells were lysed at 5 ϫ 10 7 cells͞ml in EB-1 lysis buffer (0.5% Nonidet-P 40͞140 mM NaCl͞50 mM Tris, pH 7.5) containing 5 mM EGTA, 5 mM EDTA, and the protease inhibitor mix. Lysates were run on 4-20% or 4-12% Tris SDS͞polyacrylamide gels (NOVEX) and immunoblotted with R878 antiserum.
Cleavage of Flag-Tagged ␥ c by Thymocyte Lysates. ␥ c was cloned into the pFLAG-CMV-1 vector (Kodak) and transfected into 293 T cells by calcium phosphate (5 Prime 3 3 Prime). The resulting FLAG-␥ c protein was purified by anti-FLAG antibody (M2)-conjugated affinity beads (Kodak). Total thymocytes from 4-week-old C57BL͞6 mice were treated with goat-anti-hamster IgG (GAHIgG, PharMingen), anti-CD3 ϩ GAHIgG. Cells were lysed with EB-1 lysis buffer lacking protease inhibitors and calcium chelators or containing calpastatin. The purified FLAGtagged ␥ c was incubated with the indicated cell lysates or with 0.1 M purified m-calpain (Calbiochem 208715) for 30 min at 37°C. Lysates then were run on SDS gels and analyzed by Western blotting with anti-FLAG M2 antibody (Kodak) using ECL.
Isolation of CD4 ؉ Thymocytes. Thymocytes (400 ϫ 10 6 ) from C57BL͞6 mice (The Jackson Laboratory) in 1 ml of Hanks' balanced salt solution (HBSS) were incubated with an equal volume of peanut agglutinin (0.5 mg͞ml, Sigma) for 10 min at room temperature (25) . Cells then were loaded onto 10 ml of 2% BSA in HBSS and allowed to stand for 30 min at room temperature. CD4
ϩ cells were purified from the cells at the interface by complement-mediated depletion of Ia ϩ and CD8 ϩ cells using anti-Ia mAb M5114 and anti-CD8 mAb 3.155.
IL-7-Dependent Protection Against Apoptosis in Thymocytes.
Total thymocytes from 4-week-old C57BL͞6 mice, of which 91% were CD4 ϩ CD8 ϩ double positive cells, were resuspended at 2 ϫ 10 6 ͞ml in RPMI medium 1640 containing 10% charcoal-treated FBS (Cocalico Biologicals, Reamstown, PA), and incubated for 30 min at 37°C with 400 nM calpastatin. Cells were transferred at 2ϫ 10 5 cells͞well in 100 l to 96-well plates (Costar) that were precoated overnight at 4°C with 30 l of 50 g͞ml of both anti-CD3 and anti-CD28 (375.1 mAb) (30) or with purified polyclonal hamster IgG (PharMingen) in 0.1 M Tris, pH 9.5. After 1 hr (37°C, 5% CO 2 ), 20 ng͞ml recombinant murine IL-7 (R & D Systems) was added. Cells were harvested 18 hr later and stained with ethidium bromide, and 10 4 cells͞condition were analyzed by FACSort, as described (31) . The % viable (cells not staining) and nonviable cells then was determined.
Electrophoretic Mobility Shift Assays. Human peripheral blood lymphocytes were isolated from normal donors, stimulated with 1 g͞ml of phytohemagglutinin-L (Boehringer Mannheim) for 48 hr, washed, and rested overnight in medium lacking phytohemagglutinin. Cells were incubated for 30 min in RPMI medium 1640 (without calcium nitrate, GIBCO͞ BRL) containing 10% FBS and 2.5 mM CaCl 2 with or without 20 M purified human calpastatin domain I peptide (amino acids 184-217, synthesized by M. Berne, Tufts University) (32) or EGTA. Where indicated, 4 M ionomycin was added for 30 min at 37°C with gentle agitation. Cells then were stimulated with 1.3 nM human IL-2 for 15 min at 37°C, lysed in 20 mM Hepes, pH 7.8͞450 mM NaCl͞0.4 mM EDTA͞2.5 mM FIG. 1. The small subunit of calpain associates with ␥c. Using the yeast two-hybrid system with the ␥c cytoplasmic domain as bait, two cDNAs were identified that corresponded to the C-terminal region of the small subunit of calpain distal to the autoproteolytic cleavage site (35). EGTA͞0.5 mM DTT͞25% glycerol͞0.5 mM 4-[2-aminoethyl]-benzenesulfonyl fluoride hydrochloride͞10 g/ml leupeptin͞10 g/ml aprotinin by the freeze-thaw method, and electrophoretic mobility shift assays were performed (23) using an end-labeled double-stranded ␤-casein probe (5Ј-AGCTTA-GATTTCTAGGAATTCG-3Ј) and 15 g of protein (determined using the Bio-Rad Protein Assay kit) in each lane.
RESULTS
Association of ␥ c and Calpain in the Yeast Two-Hybrid System. To identify additional proteins capable of associating with the cytoplasmic domain of ␥ c , we used a yeast two-hybrid method (27, 33) in which the entire ␥ c cytoplasmic domain was used as bait (see Material and Methods). Of 10 7 cDNA clones screened, 21 specifically interacting clones were identified, two of which encoded amino acids 134-268 (clone A) and amino acids 141-268 (clone B), respectively, of the small subunit of human calpain (Fig. 1) .
Calpains are calcium-activated neutral proteases that are expressed in many mammalian tissues (34) (35) (36) , including lymphocytes (37) , and can catalyze the cleavage of a wide range of proteins, including enzymes, transcription factors, cytoskeletal proteins, and members of receptor signaling pathways (34) (35) (36) . Each calpain has a unique 80-kDa large subunit but shares a common 30-kDa small subunit (34) (35) (36) . Calpain is converted from an inactive proenzyme to its active form by autoproteolytic cleavage of both subunits, with cleavage of the small subunit to a 17-kDa C-terminal fragment that remains associated with the large subunit (35) . As the clones we identified in the two-hybrid analysis were C terminally biased, our data suggest that autoproteolytically cleaved active calpain can interact with ␥ c .
Cleavage of ␥ c by Calpain. Efforts to coprecipitate calpain and ␥ c yielded at best low levels of coprecipitation (data not shown). However, physiologically relevant interactions can potentially either be too transient or of insufficient affinity to allow efficient coprecipitation. Furthermore, it was conceivable that efficient interaction might occur only after calpain activation and that such activation might cleave ␥ c , decreasing our ability to observe the interaction by coprecipitation. Therefore, we investigated the ability of calpain to cleave ␥ c . Proteins that are targets for calpain typically have a region rich in proline (P), glutamic acid (E), serine (S), and threonine (T) flanked by clusters of positively charged amino acids (28, 38, 39) . Using the PEST-FIND computer program (28), we found such a region beginning in the SH2-subdomain homology region (3) of the human ␥ c cytoplasmic domain. This sequence (GLAESLQPDYSE; PEST score ϭ Ϫ3.95, scores Ͼ Ϫ5 are significant), which is flanked by positively charged amino acids, was conserved in canine ␥ c , and an even higher PEST score was found in murine ␥ c (GLTESLQPDYSE; PEST score ϭ ϩ0.59). Although PEST sequences are not necessarily required for calpain-mediated cleavage of substrates (40) , it was striking that calpain could cleave in vitro-translated wild-type ␥ c ( Fig.  2A) , but not ␥ c in which the PEST region in human ␥ c was mutated from GLAESLQPDYSE to GLAVGLQLDYSE (which does not score as a valid PEST sequence) (Fig. 2B) .
We next evaluated calcium-dependent cleavage of ␥ c in YT cell lysates. YT cells were washed with calcium-free PBS and lysed with Brij 96 lysis buffer. Lysates were incubated with 5 mM CaCl 2 or 10 mM EGTA ϩ 2.5 mM EDTA for 0 to 60 min. Reactions were stopped by the addition of EGTA (final concentration 10 mM) and protease inhibitors, and lysates were immunoprecipitated with chicken anti-human ␥ c antibody (Fig. 2C, lanes 2-10) or control IgY (Fig. 2C, lane 1) , run on SDS gels, and immunoblotted with R878 antiserum to ␥ c . The ␥ c bands were diminished in intensity only in the presence of 5 mM CaCl 2 (Fig. 2C, lanes 4  and 7 vs. lanes 3 and 6) . Cleavage was inhibited by calpastatin (Fig.  2C, lanes 5 and 8), a specific calpain inhibitor (32, 34) , and by antipain (Fig. 2C, lane 10 vs. 9) , another potent inhibitor of calpain (41) . These data indicate that calpain was the enzymemediating cleavage of ␥ c . In addition to this calcium-activated cleavage of ␥ c in YT cell lysates, treatment of intact YT cells with ionomycin also induced ␥ c cleavage in a time-dependent manner (Fig. 3A) . Cleavage was detected only in the presence of calcium (Fig. 3A) and was increased at high concentrations of ionomycin (Fig. 3B) . As expected, cleavage of ␥ c was not seen in response to IL-2 (Fig. 3) , a stimulus that does not increase intracellular calcium concentrations (42) .
TCR Activation Mediated Proteolysis of ␥ c in Thymocytes. As noted above, IL-2 does not induce an increase in intracellular calcium and did not induce cleavage of ␥ c . However, signaling through the TCR rapidly increases intracellular calcium (28, (43) (44) (45) (46) , leading us to hypothesize that TCR-mediated calcium flux might be sufficient to activate calpain and induce cleavage of ␥ c . As X-linked severe combined immunodeficiency patients and ␥ c -deficient mice exhibit greatly diminished thymic development, indicating the importance of ␥ c in this process, we studied the possible role of ␥ c cleavage in thymocytes. We first used anti-CD3 stimulation of murine thymocytes, a treatment known to induce apoptosis (47) , as a way of increasing intracellular calcium concentrations and found that such treatment diminished the intensity of ␥ c bands in a time-dependent manner ( kDa, at least in part due to the lack of glycosylation. We confirmed a report that in vitro-translated c-Fos is sensitive to cleavage by calpain, whereas chloramphenicol acetyltransferase is not (65) . Murine wild-type and PEST-mutated ␥c yielded similar results to those shown for human ␥c (data not shown). (C) Proteolysis of ␥c by calpain in YT cells. YT cell lysates were incubated with 5 mM CaCl2 (lanes 4, 5, and 7-10) or 10 mM EGTA ϩ 2.5 mM EDTA (lanes 3 and 6) at 37°C for 0-60 min, and reactions were stopped by the addition of 10 mM EGTA͞10 g/ml leupeptin (Boehringer Mannheim)/240 g͞ml 4-[2-aminoethyl]-benzenesulfonyl fluoride hydrochloride͞10 g͞ml aprotinin (ICN). In lanes 4, 7, and 10, 20 M calpastatin or 50 g͞ml antipain also were added. Reactions were stopped with 10 mM EGTA and the protease inhibitor mix. Lysates were immunoprecipitated with chicken anti-human ␥c (lanes 2-10) or control chicken IgY (lane 1), and immunoblotted using R878 antiserum to ␥c. As R878 antiserum recognizes the C-terminal end of ␥c, cleavage in the cytoplasmic domain would result in immunoreactive fragments too small to be retained on these gels. The cleavage was specific, as shown by the lack of general degradation of cellular proteins as detected by Coomassie staining (data not shown).
that ␥ c was being cleaved by calpain. In contrast, anti-CD3 treatment did not induce a general degradation of cellular lysate proteins, as detected by Coomassie staining (Fig. 4B) . To further confirm the activation of calpain in thymocytes, 293 T cells were transfected with a FLAG-tagged ␥ c , and anti-FLAG immunoprecipitated protein was added to lysates from thymuses stimulated with control IgG or anti-CD3 in the presence vs. absence of calpastatin. Cleavage was seen with anti-CD3 and inhibited by calpastatin (Fig. 4C, lanes 2 and 3) , again implicating calpain in the cleavage. As expected the FLAG-␥ c protein was cleaved by purified calpain, but not by PBS (Fig. 4C, lane 5 vs. 4) .
Calpain Inhibitors Minimally Augmented IL-7-Dependent Protection from Apoptosis Induced by TCR Stimulation in Thymocytes. Cytokines that signal via ␥ c , including IL-2, IL-4, and IL-7, can protect against apoptosis in lymphocytes by acting as survival factors (48) (49) (50) (51) . We therefore asked whether TCRmediated cleavage of ␥ c might influence cell viability after TCR stimulation. A calpastatin peptide alone did not significantly increase survival in thymocytes (consistent with previous observations; see ref. 25 ), but had a modest but reproducible positive effect on the ability of IL-7 to enhance cell survival (Table 1) . However, the degree of protection did not achieve statistical significance and its physiological relevance remains unclear. The fact that IL-7 ϩ calpastatin had such a modest effect may reflect incomplete inhibition of calpain by calpastatin or that calpainand ␥ c -independent mechanisms are primarily involved. Another inhibitor of calpain, AllnM, also exhibited similarly weak (and not statistically significant) effects on the ability of IL-7 to confer protective effects against anti-CD3-induced apoptosis (data not shown).
Calpain Inhibitors Increased Anti-CD3-Induced Proliferation and Reversed Ionomycin-Mediated Decreases in IL-2-Induced Stat5 Activation. In contrast to the minor effect of calpastatin inhibitors on apoptosis, AllnM greatly increased anti-CD3-induced proliferation of CD4 ϩ thymocytes (consistent with a previous report, ref. 25 ), but anti-␥ c antibodies that block cytokine binding (52) inhibited this effect (Fig. 5) . These data indicate that activated calpain can inhibit the immunological response of cytokine(s) whose receptor(s) contain ␥ c . Finally, we examined the effect of calpain inhibitors on STAT protein activation (Fig.  6) . STAT protein DNA binding activity is induced in phytohemagglutinin-activated human peripheral blood lymphocytes stimulated with IL-2 (Fig. 6A, lane 2) . This was diminished by the addition of ionomycin (to increase intracellular calcium) (Fig. 6A,  lane 4) , but the effect was reversed by calpastatin (Fig. 6A, lane  6) or EGTA (Fig. 6C, lane 6 vs. 4) . Together, these data support the hypothesis that calpain can modulate ␥ c -dependent signaling and suggest calpain may affect proliferation and STAT protein activation.
DISCUSSION
We have demonstrated that the small subunit of calpain, a calcium-activated neutral protease, can physically associate with the ␥ c cytoplasmic domain. This association was functionally important based on several lines of evidence. First, m-calpain could cleave in vitro-translated ␥ c in a dose-dependent manner. Second, calcium could activate cleavage of ␥ c in YT lysates, and this cleavage was diminished by calpain inhibitors. Third, ionomycin treatment of intact YT cells induced cleavage of ␥ c in a calcium-dependent manner. Fourth, in murine thymocytes, anti-CD3 induced cleavage of ␥ c , and this cleavage was diminished by a calpain inhibitor. Fifth, calpain inhibitors can enhance anti-CD3-induced proliferation and this increase is prevented by anti-␥ c blocking antibodies. Finally, calpain inhibitors can reverse ionomycin-induced decreases in STAT protein activation.
Although calpain has been implicated as playing an important role in T cell biology (24) (25) (26) , the relevant substrates have Thymocytes from 4-week-old C57BL/6 mice were treated with hamster IgG (control) or anti-CD3 ϩ anti-CD28 (TCR-induced) in the presence or absence of IL-7 and calpastatin. TCR-induced cells treated with IL-7 ϩ calpastatin had significantly less death (37.8%) than cells treated with calpastatin alone (45.5%) ‫ء(‬ P Ͻ 0.05 by Student t test). The % induced cell death is the difference between the control and TCR-induced death.
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Proc. Natl. Acad. Sci. USA 94 (1997) 11537 remained obscure. We now show that ␥ c is a substrate for calpain. ␥ c is the first member of the cytokine receptor superfamily that has been shown to be a target for calpain. Although the cytoplasmic domains of IL-2R␣ and IL-2R␤ are not rich in P, E, S, and T residues, a number of other cytokine receptors, including human ␤ c (a shared component of the receptors for IL-3, IL-5, and granulocyte͞macrophage colony-stimulating factor), gp130 (a shared component of the receptors for IL-6, IL-11, leukemia inhibitor factor, ciliary neurotropic factor, oncostatin M, and cardiotropin 1), IL-4R␣, IL-7R␣, and IL-9R␣ have cytoplasmic domains with significant PEST scores ( Table 2 ). It will be interesting to determine if any of these cytokine receptors are also substrates for calpain. Given that relatively high concentrations of calcium are required for activation of calpain in vitro and that antigenic peptide concentration correlates with the increase in calcium achieved (53) , the strongest antigenic peptide signals would be most expected to activate calpain and promote the cleavage of ␥ c . As ␥ c is required for signaling in response to a variety of cytokines, the cleavage of ␥ c could represent a mechanism by which these responses can be controlled. Because activation of mature T cells by antigen generally results in an IL-2-dependent expansion of cells, it is clear that in this context that calpain is not being activated to a sufficient extent to prevent IL-2 signaling. Thus, ␥ c is not being quantitatively inactivated or it is being replaced at a rate sufficient to allow for ␥ c -dependent proliferation; however, the ability of a calpain inhibitor to augment anti-CD3-induced proliferation suggests that cleavage of ␥ c by calpain can modulate proliferation (Fig.  5) .
It is interesting that TCR-induced apoptosis during intrathymic development is known to require an increase in intracellular calcium (29, 43, 45, 46) and that the strongest antigenic signals are most effective in inducing thymic or peripheral deletion of cells (54) (55) (56) (57) (58) (59) (60) (61) (62) . It thus is conceivable that TCR-activated proteolysis of ␥ c could predispose to apoptotic death. This type of mechanism is consistent with the ability of cytokines that signal via ␥ c , such as IL-2 and IL-7, to protect against apoptosis in lymphocytes (48, 50, 63, 64) , and suggests that inactivation of ␥ c would diminish cytokine-induced survival signals. Nevertheless, it is clear that other mechanisms also must be operational given the very modest effect of calpain inhibitors on the ability of IL-7 to protect against anti-CD3-mediated death. In contrast, calpain inhibitors had much more potent effects related to proliferation and STAT protein activation.
Although further work is needed to clarify the physiological role that calpain plays in regulating signaling by ␥ c -dependent cytokines, our data provide a key insight that calpain can associate with and cleave ␥ c , suggesting that TCR-mediated proteolysis of ␥ c by calpain could represent a mechanism by which cytokine responsiveness can be controlled, and thereby providing the basis for additional investigation.
